Autotransfusion Systems Market to grow at a CAGR of 4.5% during 2024-2028
The Autotransfusion Systems Market is expected to grow at a CAGR of 4.5% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 280.8 million. In the medical field, allogeneic blood transfusions are utilized during surgical procedures to mitigate complications resulting from blood loss. However, the potential risks associated with allogeneic blood transfers, such as transfusion-related acute lung injury (TRALI), ABO incompatibility leading to hemolytic transfusion reactions (HTRs), and transfusion-associated sepsis (TAS), can deter their acceptance. Furthermore, the possibility of bacterial and viral infections, coupled with limited availability and high costs of blood products, pose significant challenges to the widespread use of allogeneic blood transfusions.
Get more information on Autotransfusion Systems Market by requesting a sample report
Technavio analysts predict that the Autotransfusion products subsegment will lead the Type segment during 2024 and 2028 Autotransfusion systems market is primarily driven by the demand for autotransfusion products, which account for the largest segment. These advanced products facilitate the autologous blood transfusion process during surgical procedures, enabling the collection and processing of a patient's own blood during intraoperative and postoperative stages. This reduces the risks associated with allogeneic transfusions from donors or blood banks. The escalating number of cardiac and orthopedic surgeries, coupled with the increasing need for blood volume replacement, fuels the market growth.
Here are the various ways based on which the market is segmented:
There are several factors that are causing the market to flourish rising number of cardiac and orthopedic surgeries
Learn which are the obstacles that the market is experiencing in the way of its growth by accessing the free PDF report
Autotransfusion is a medical technique that allows the reinfusion of a patient's own blood, which is collected during surgery or other medical procedures, back into their circulatory system. Two common types of autotransfusion are Concentrated-blood autotransfusion (CBA) and Whole-blood autotransfusion (WBA). CBA separates the blood components, while WBA transfuses whole blood after collection. However, autotransfusion carries risks such as bacterial contamination, hemolysis, and coagulopathies. Systematic reviews have shown that the risk of adverse events, including bacterial contamination and hemolysis, is lower with autologous transfusion than with allogeneic transfusion. Autotransfusion systems include extracorporeal devices like cell salvage and cell saver systems, pericardial drains, and limb exsanguination with extremity tourniquets. These systems ensure hemodynamic stability during the procedure and minimize the need for allogeneic transfusion. Laboratory testing is crucial to ensure the safety of autotransfused blood. Risk factors for bacterial contamination include amniotic fluid contamination during cesarean sections and obstetrical hemorrhage. The washing process, centrifugation, and shed blood filtration are essential steps to minimize these risks. Despite the benefits, autotransfusion carries risks, including adverse events such as hemolysis, coagulopathies, and bacterial contamination. Proper use of autotransfusion systems, laboratory testing, and adherence to guidelines can minimize these risks and improve patient outcomes.
According to Technavio, the autotransfusion systems market is a significant segment within the expansive global healthcare equipment industry. This sector encompasses firms involved in the research and development (R&D) of various product categories, such as capital equipment, instruments, implants, accessories, and consumables. These products are utilized for the diagnosis, monitoring, and treatment of diverse diseases. The global healthcare equipment market's size is determined by the consolidated revenue generated by manufacturers of diagnostic equipment and devices. The healthcare equipment sector is segmented into Devices, which includes advanced, differentiated, and clinically validated data-driven devices.
The Autotransfusion Systems Market is experiencing significant growth, fueled by the rising number of cardiac and orthopedic surgeries. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/